## VHL Gene Inactivation in Clear Cell RCC **Key Point:** Loss of chromosome 3p and inactivation of the VHL (von Hippel-Lindau) tumor suppressor gene occurs in approximately 80–90% of sporadic clear cell renal cell carcinomas, making it the most frequent genetic alteration in this histotype. ### Mechanism of VHL Loss 1. VHL protein normally targets hypoxia-inducible factor (HIF) for proteasomal degradation 2. Loss of VHL → HIF accumulation → upregulation of VEGF, PDGF, and other angiogenic factors 3. Results in constitutive angiogenesis and tumor growth ### Other RCC Subtypes and Their Genetic Associations | RCC Subtype | Primary Genetic Alteration | Gene/Chromosome | Frequency | |---|---|---|---| | Clear cell | Loss 3p / VHL inactivation | VHL | 80–90% | | Papillary (Type 1) | Gain 7, 17, 20 | MET amplification | ~40% | | Papillary (Type 2) | Loss 3p | SETD2, BAP1, PBRM1 | Variable | | Chromophobe | Loss 1, 2, 6, 10, 13, 17, 21 | Multiple | Polysomy | | Oncocytoma | Gain 11q | FLCN (benign) | ~80% | **High-Yield:** VHL loss is so characteristic of ccRCC that it is considered a defining feature and is used in molecular classification of renal tumors. **Clinical Pearl:** Patients with hereditary VHL syndrome (von Hippel-Lindau disease) have germline VHL mutations and develop multiple ccRCCs with near 100% penetrance by age 60, often bilateral and multifocal. ### Why VHL is the Answer VHL inactivation is the initiating event in the majority of ccRCC cases and is present in both sporadic and hereditary forms. This makes it the single most important and frequently tested genetic alteration in renal cell carcinoma pathology. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.